Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Astrazeneca Share News (AZN)
AZN Share
Price
AZN Share
News
AZN Share
Chat1
AZN Share
Trades22,458
AZN
Live RNS
AZN Share
Charts
AZN Level 2
Console
AZN Live
Share Price
AZN Broker
Ratings
AZN Directors
Deals
AZN Financial
Diary
AZN
Fundamentals
AZN Short
Positions
AZN
Media
AZN Company
Research
AZN Company
Timeline
Astrazeneca Information
Share Price Information for Astrazeneca (AZN)
Share Price is delayed by 15 minutes
Get Live Data
14,318.00
256.00 (1.82%)
Bid:
14,256.00
Ask:
14,262.00
Spread:
6.00 (0.042%)
Market Cap:
£222.05b
Last checked at -
Last checked at 
Intraday Astrazeneca Share Chart
Astrazeneca News
10 Apr 2026
LONDON BROKER RATINGS: Berenberg says 'buy' Elixirr International
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday:
2 Apr 2026
UK finalises US pharma deal granting tariff-free access for British medicines
* Agreement reached as part of a wider US-UK trade accord
2 Apr 2026
FTSE 100 closes higher after Britain's move to hold talks on Strait of Hormuz
April 2 (Reuters) - London's FTSE 100 stock index closed higher on Thursday after Britain said it would host talks on reopening the Strait of Hormu...
2 Apr 2026
AstraZeneca hails encouraging data for liver cancer drug regimen
(Alliance News) - AstraZeneca PLC on Thursday posted encouraging phase-three trial results for its liver cancer treatment combination.
2 Apr 2026
Trump administration readies new tariffs on select drugmakers, Bloomberg News reports
April 1 (Reuters) - The Trump administration is set to announce tariffs as soon as Thursday on drugmakers that have not struck deals guaranteeing ...
31 Mar 2026
FOCUS-Drugmakers delay some European launches with a wary eye on Trump's pricing policies
* Trump most-favored-nation deals cause pricing uncertainty
31 Mar 2026
REFILE-FOCUS-Drugmakers delay some European launches with a wary eye on Trump's pricing policies
* Trump most-favored-nation deals cause pricing uncertainty
Follow the stocks
